10 Results for "

LXR antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (10)

10 Results for "LXR antagonist" in MCE Product Catalog:

  • Targets Recommended:
37
37 Cited Publications
Art. -Nr.: HY-108688
CAS. Nr.: 1221277-90-2
Reinheit:  99.37%
Target:  

LXR

Forschungsgebiete:  

Metabolic Disease

GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectively.
loading...
    loading...
Art. -Nr.: HY-W002314
CAS. Nr.: 2491-38-5
2-Bromo-4'-hydroxyacetophenone is a PTP1B inhibitor with a Ki value of 42 μM. 2-Bromo-4'-hydroxyacetophenone is also an intermediate. 2-Bromo-4'-hydroxyacetophenone can be used in the synthesis of LXRα/β antagonists. 2-Bromo-4'-hydroxyacetophenone can be used in research on hematological diseases .
loading...
    loading...
Art. -Nr.: HY-139576B
Reinheit:  ≥97.0%
Synonyms: DUR-928 trimethylamine
Larsucosterol (DUR-928) trimethylamine, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol trimethylamine as a potent endogenous regulator decreases lipogenesis. Larsucosterol trimethylamine inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1 .
loading...
    loading...
Art. -Nr.: HY-139576
CAS. Nr.: 884905-07-1
Synonyms: DUR-928
Larsucosterol (DUR-928), a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol as a potent endogenous regulator decreases lipogenesis. Larsucosterol inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1 .
loading...
    loading...
Art. -Nr.: HY-N2273
CAS. Nr.: 19942-02-0
Gymnestrogenin is a pentahydroxytriterpene from the leaves of Gymnema sylvestre R.Br . Gymnestrogenin is a LXR antagonist with IC50s of 2.5 and 1.4 μM for LXRα and LXRβ transactivation, respectively. Gymnestrogenin reduces the transcriptional activity of LXR even on its own promoter, thus reducing the mRNA expression .
loading...
    loading...
Art. -Nr.: HY-134969
CAS. Nr.: 895700-18-2
Target:  

LXR

Forschungsgebiete:  

Metabolic Disease

TFCA is a liver X receptor α (LXRα) antagonist. TFCA inhibits ligand-activated LXRα coactivation and transcriptional expression of the downstream target genes involved in fatty acid synthesis. TFCA attenuates ligand-induced lipogenesis and fatty liver by selectively inhibiting LXRα in the liver .
loading...
    loading...
Art. -Nr.: HY-170570
CAS. Nr.: 3053859-57-4
PFM046 is the antagonist for liver X receptor (LXR), that inhibits the activation of LXRα and LXRβ with IC50 of 2.04 μM and 1.58 μM. PFM046 inhibits the expression of SCD1 and FASN, upregulates the expression of ABCA1, and exhibits antitumor efficacy in mouse models .
loading...
    loading...
Art. -Nr.: HY-139576C
CAS. Nr.: 2655654-16-1
Synonyms: DUR-928 ammonium
Forschungsgebiete:  

Metabolic Disease

Larsucosterol (DUR-928) ammonium, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol ammonium as a potent endogenous regulator decreases lipogenesis. Larsucosterol ammonium inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1 .
loading...
    loading...
Art. -Nr.: HY-139576A
CAS. Nr.: 1174047-40-5
Synonyms: DUR-928 sodium
Larsucosterol (DUR-928) sodium, a cholesterol metabolite, is a potent liver X receptor (LXR) antagonist. Larsucosterol sodium as a potent endogenous regulator decreases lipogenesis. Larsucosterol sodium inhibits the cholesterol biosynthesis via decreasing mRNA levels and inhibiting the activation of SREBP-1 .
loading...
    loading...
Art. -Nr.: HY-108688R
CAS. Nr.: 1221277-90-2
Target:  

Reference Standards LXR

Forschungsgebiete:  

Metabolic Disease

GSK2033 (Standard) is the analytical standard of GSK2033 (HY-108688). This product is intended for research and analytical applications. GSK2033 is a LXR antagonist with pIC50s of 7 and 7.4 for LXRα or LXRβ, respectively.
loading...
    loading...